Your browser doesn't support javascript.
loading
Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia.
Sorensen, Sonja; Wildgust, Mark; Sengupta, Nishan; Trambitas, Cristina; Diels, Joris; van Sanden, Suzy; Xu, Yingxin; Dorman, Emily.
Afiliación
  • Sorensen S; Modeling and Simulation, Evidera, Bethesda, Maryland. Electronic address: Sonja.sorensen@evidera.com.
  • Wildgust M; Janssen Research & Development, Raritan, New Jersey.
  • Sengupta N; Janssen Global Services, Raritan, New Jersey.
  • Trambitas C; Janssen Global Market Access & Policy-Oncology, Toronto, Ontario, Canada.
  • Diels J; Janssen Health Economics & Market Access EMEA Statistics & Modelling, Beerse, Belgium.
  • van Sanden S; Janssen Health Economics & Market Access EMEA Statistics & Modelling, Beerse, Belgium.
  • Xu Y; Meta Research, Evidera, Waltham, Massachusetts.
  • Dorman E; Modeling and Simulation, Evidera, Bethesda, Maryland.
Clin Ther ; 39(1): 178-189.e5, 2017 Jan.
Article en En | MEDLINE | ID: mdl-28062113
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Purinas / Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Quinazolinonas / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Ther Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Purinas / Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Quinazolinonas / Anticuerpos Monoclonales Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Clin Ther Año: 2017 Tipo del documento: Article